Some medical technologies that use artificial intelligence might benefit patients but result in a drop in health system revenues. This could make widespread adoption of AI in medicine a tough sell.
Healthcare is a world of perverse incentives. One person’s waste is another person’s annual bonus. If you have shares in Novo Nordisk, you don’t really want people to eat more fruits and vegetables, because then sales of diabetes meds might drop. The same is true on a larger scale for hospital systems that get paid to conduct tests and perform surgeries instead of keeping people healthy.
It doesn’t pay—yet—to keep people healthy. Many entrepreneurs and government leaders are dragging the American healthcare system away from the fee-for-service model, but the road to pay for performance medical care is long and winding.
HeartFlow is the perfect example of how a positive change for patients could mean a drop in health system revenues. The company’s goal is to improve care for heart disease by avoiding both under- and over-treatment. HeartFlow takes data from a CT scan and turns it into a 3D model of the veins and arteries that supply blood to the heart.
“If our system is adopted, the net annual savings would be $2 billion for one commercial payer,” said John Stevens, MD and president of HeartFlow. “We could avoid 250,000 unnecessary procedures and even save 30,000 lives.” Stevens shared these shocking numbers at HLTH 2018 in early May in Las Vegas.
Image Credit: From article
News This Week
From Frontiers Forum: How can research translate to R&D? Or a whole new business venture? In a panel session at Science Unlimited 2019, Holtzbrinck Publishing Group CEO Stefan von Holtzbrinck, Life Biosciences CEO [...]
More and more security holes are appearing in cryptocurrency and smart contract platforms, and some are fundamental to the way they were built. Early last month, the security team at Coinbase noticed something strange [...]
“The most crucial result of this work is the correlation between form and function in supercapacitor materials,” states first author Dina Ibrahim Abouelamaiem. She elaborates that “our research is driven by the need for [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - June 18 2019 Since [...]
A new study by the Environmental Working Group reveals that: “Major food companies like General Mills continue to sell popular children’s breakfast cereals and other foods contaminated with troubling levels of glyphosate, the cancer-causing [...]
A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by University of California, [...]
In a paper published this week in Nature ("Freestanding crystalline oxide perovskites down to the monolayer limit"), materials science researchers at the University of California, Irvine and other institutions unveil a new process for [...]